Following non-submission
AWMSG advice |
||
Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, mequitazine (Primalan®) cannot be endorsed for use within NHS Wales for the treatment of allergic conditions such as hay fever, perennial rhinitis, urticaria, pruritis of allergic origin and allergic reactions associated with insect bites and stings. |
||
|
||
Medicine details |
||
Medicine name | mequitazine (Primalan®) | |
Formulation | 5 mg tablet | |
Reference number | 1346 | |
Indication | Treatment of allergic conditions such as hay fever, perennial rhinitis, urticaria, pruritis of allergic origin and allergic reactions associated with insect bites and stings |
|
Company | Pierre Fabre Ltd | |
BNF chapter | Respiratory system | |
Submission type | Non-submission | |
Status | Not endorsed (Statement of Advice) | |
Date of issue | 01/11/2011 |